Apply Today!

Deadline Approaching! Apply Now!

The ATS Drug Device Discovery and Development Committee invites you to apply to the eighth Annual BEAR Cage (Building Education to Advance Research) competition!

Learn more, and see where one of our past winners is today!

Deadline: Feb.28, 2022

Ziskind Clinical Research Scholar Award

The Ziskind Clinical Research Scholar Award is an ATS Scholarship Award that honors pulmonary and critical care fellows to recognize the best and the brightest individuals in clinical research. View past Ziskind Clinical Research Scholar Awardees.

Deadline: March 15, 2022
Learn more and apply!

Harold Amos Medical Faculty Development Program (AMFDP)

The Harold Amos Medical Faculty Development Program offers four-year postdoctoral research awards to physicians, dentists, and nurses from historically marginalized backgrounds. Scholars should be committed to working toward eliminating health disparities by achieving senior rank in academic medicine, dentistry, or nursing.

Deadline: March 16, 2022
Learn more and apply

American Association of Bronchology and Interventional Pulmonology (AABIP) Grant

AABIP remains committed to fostering excellence in patient care, medical education and interventional pulmonology research, and is pleased to request applications for its annual research grant of up to $20,000.  

Deadline: 11:59 p.m. ET, April 18, 2022
Learn more and apply!

Upcoming Events

Upcoming Journal Clubs

The Section on Genetics and Genomics and the Assembly on Respiratory Cell & Molecular Biology present, “Identification of LZTFL1 as a candidate effector gene at a COVID-19 risk locus.”

When: 12 p.m. ET,  Feb. 25, 2022
Register now.

Section on Medical Education presents, “They Don’t See a Lot of People My Color:  A Mixed Methods Study of Racial/Ethnic Stereotype Threat Among Medical Students on Core Clerkships”

When: 4 p.m. ET, March 28, 2022
Register now.                   

Assembly on Pulmonary Infections and Tuberculosis Webinar, “COVID-19 Vaccines: The Evolving Policy Questions”

When: 12 p.m. ET, Feb. 24, 2022
Register now.

COVID-19 Real-Time Learning Network Clinician Call, “Update on Serology Testing”

When: 3 p.m. ET,  Feb. 26, 2022
Register here, and catch up on previous clinician calls!

Assembly on Thoracic Oncology Early Career Professionals Working Group Presents a Fireside Chat with ATS Vice President, M. Patricia Rivera, MD, ATSF

When: 4 p.m. ET, March 3, 2022
Register now!

ATS Critical Care (CC) Assembly's, Early Career Professionals Working Group Presents, “Keeping up in Unusual Times” as part of the “Critical Care Careers: Charting the Uncharted” Series

When: 4 p.m. ET, March 7, 2022
Register now!

Working with Industry and Working in Industry - A Career Development Webinar

Join the DDDD Committee for ATS Webinar Series #1 - Career Development! This panel will discuss the intersection of working with and for industry featuring DDDD member panelists and special guest former ATS President, Monica Kraft, MD, ATSF.

When: 12 p.m. ET, March 18, 2022
Register now.

New Trials Listed on ATS Clinical Trial Resources Site

Three new currently recruiting trials by AstraZeneca were listed on the ATS Clinical Trial Resources page. The goal of this page is to connect the ATS community to current, ongoing clinical trials in pulmonary, critical care, and sleep medicine being conducted by participating pharmaceutical and device companies.
MAHALE is a Phase III research study to test the hypothesis that benralizumab, an eosinophil depleting antibody, will reduce exacerbation rates compared with placebo on top of standard-of-care therapy in adult patients with non-cystic fibrosis bronchiectasis with eosinophilic inflammation.

MANDARA is a Phase III study in patients with relapsing or refractory EGPA on corticosteroid therapy with or without stable immunosuppressive therapy.
NATRON is multicenter, randomized, double-blind (DB), parallel-group, placebo-controlled, 24-week Phase III study to compare the efficacy and safety of benralizumab versus placebo administered by SC injection Q4W in patients with hypereosinophilic syndrome (HES).

Please visit the ATS Clinical Trial Resources page to learn more about these trials or contact Dayna Howell for additional information.

Results Are In! 2021 Assembly Challenge

The ATS would like to thank all ATS Assemblies for their outreach efforts and generosity during the 2021 ATS Assembly Challenge, and the results are in:

• Most dollars raised: Allergy Immunology & Inflammation with $31,389!
• Highest member participation: Nursing with eight percent!
• Most first-time donors in Dec:  Clinical Problems with five new donors!  

Your support has been crucial for developing the next generation of researchers, clinicians, and medical educators, who are the real winners of this challenge!
To learn more about the ATS Research Program or to make a gift, visit research.thoracic.org. Congratulations and thank you to everyone who participated!

Global Lung Health Organizations Partner for Inaugural World Bronchiectasis Day

Global lung health organizations from the United States, Europe, Australia, and Asia have joined together to announce the declaration of World Bronchiectasis Day on July 1, 2022, to raise awareness of bronchiectasis and its increased prevalence in many countries.

To learn more about bronchiectasis, events leading up to and on July 1, a list of collaborating organizations, and information about supporting the annual World Bronchiectasis Day, visit worldbronchiectasisday.org.